trametinib – Patient Worthy

https://unsplash.com/photos/Y14ONzYtxb4

Trametinib is a Major Advance in Treating Rare Ovarian Cancer

Post author:Alyssa Stevens
Post published:February 17, 2022
Post category:Ovarian Cancer

According to a recent article, trametinib has proven to be successful in treating a rare ovarian cancer subtype, which is a major advancement in treating those with this rare ovarian…

CLICK HERE TO SHARE YOUR STORY!

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More